Federal Innovation Funding Briefing: Week of August 22, 2026 – August 28, 2026

FAA BEYOND Phase 2 Opens Drone Doors

The FAA's [OTA] BEYOND Phase 2 opportunity lands the same week DOT and the FAA announced they will double the program, selecting up to eight additional state, local, tribal, and territorial lead participants to expand advanced drone operations nationwide. This RallyReport tags mission autonomy plus navigation and sensing, so the real openings are for subcontractors and tech vendors who can plug into a lead participant's operations rather than competing head-on for a slot. Note the gotcha: Phase 2 is data collection for rulemaking, not commercial clearance — the Part 108 BVLOS rule remains unfinished and past its own deadline, so position for higher-altitude, longer-range, larger-cargo test flights rather than turnkey commercial revenue. Small firms in pipeline, power-line, and public-safety drone work should be talking to existing participants now, before the new leads are picked.

Air Force Zero Trust Buying Is Live

The [BAA] STAR-FISH CALL 017 Secure By Design opportunity pairs space domain awareness with zero trust architecture, and it arrives while the Air Force is actively spending on this exact stack — GDIT just booked a $120M task order to deploy an AI-enabled zero trust solution across 187 bases under the Next Generation Gateway program. For small businesses, that signals durable demand for micro-segmentation, identity, and 'assume breach' tooling that can bolt onto space and ground systems. STAR-FISH is a rolling call BAA, so treat it as a standing on-ramp: submit a tight white paper aligned to a specific Secure By Design objective rather than waiting for a fixed RFP cycle, and lean on the fact that zero trust is now mandated architecture, not a nice-to-have.

Health AI Wants Labeled Clinical Data

Two opportunities this week — NIH's [CONTRACT] Cardiac CT Anatomical Segmentation Dataset and DHA's [OTA] Military Injury Cause Coding (NLP/ML) — point to a clear buying pattern: agencies are paying for AI-ready datasets and data curation, not just finished models. That aligns with NIH's broader push, including the Common Fund's PRIMED-AI program built to develop AI tools integrating clinical imaging with multimodal data, and an earlier $130M Bridge2AI commitment to build AI-ready biomedical datasets. The practical read for consultants and small firms: annotation, segmentation, and NLP-coding services are winnable, lower-barrier entry points that build past performance with NIH and DHA. Frame proposals around labeled-data delivery, interoperability standards, and clinical validation — the unglamorous data engineering that these programs consistently fund ahead of model development.